BSE filing, NSE: APIS. Summary written from the filing by ALFA Finder's alert engine.
Apis India Ltd: key numbers
- Share price
- ₹52.98
- Market cap
- ₹729.8 Cr
- Revenue (annual)
- ₹390.5 Cr
- Net profit (annual)
- ₹25.32 Cr
- P/E (TTM)
- 29.6×Sector 28.6×
- Promoter holding
- 74.72%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Apis India Ltd
All →Apis India Other Announcement
Apis India's board approved seeking listing of its existing equity shares on the NSE main board. No fresh issue or fund raising is involved.
Apis India Other Announcement
Apis India disclosed the officials authorised under Regulation 30(5) to determine materiality of events and make exchange disclosures. The filing lists officers and contact details only, with no transaction or business event.
Apis India Q1 FY27 Results: Net Profit ₹3.4 Cr, Up 36.0% YoY
Apis India Ltd reported revenue from operations of ₹66 Cr (-23.7% YoY) and net profit of ₹3.4 Cr (+36.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹3.4 Cr · +36.0% YoY
Apis India Board Meeting Date
Apis India will hold its board on 27 Oct 2026 to approve Q1 FY27 unaudited results. The trading window closes until 48 hours post-results declaration.
Apis India Other Announcement
Apis India Ltd filed its quarterly shareholding pattern for the period ending 30 September 2026, pursuant to Regulation 31(1)(b) of the SEBI Listing Regulations.
Apis India Annual General Meeting
Apis India Limited held its 44th Annual General Meeting on September 30, 2026, via video conferencing. Shareholders considered financial statements, director re-appointment, and auditor appointment.
Other board meeting date announcements
All →B.D. Industries (Pune) Board Meeting Date
B. D. Industries (Pune) will hold a board meeting on 14 November 2026 to consider unaudited standalone and consolidated half-year results. The agenda items are proposed only and no decision has been taken yet.
Health X Platform Board Meeting Date
Health X Platform will hold a board meeting on 14 November 2026 to approve quarterly results. Trading window stays closed until 48 hours after declaration.
Exato Technologies Board Meeting Date
Board meeting set for November 14, 2026 to approve half-year results and an ESOP scheme. Trading window closed from October 1.
Astal Laboratories Board Meeting Date
Astal Laboratories will hold a board meeting on 13 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window stays closed until 48 hours after the meeting.
Brainbees Solutions Board Meeting Date
Brainbees Solutions will hold a board meeting on November 14, 2026 to approve September 2026 quarter and half-year results. Trading window stays closed until November 16.
Senco Gold Board Meeting Date
Senco Gold schedules a board meeting on 13 November 2026 to consider unaudited quarterly and half-year results. The trading window stays closed until 48 hours after declaration.